CHG-2023-0294

Labeling Change for Semaglutidex. Facility Change for Semaglutidex — minor update. Impacts 4 markets and 2 variations.

Change Number
CHG-2023-0294
Type
Labeling Change
Product
Semaglutidex
Status
Pending
Owner
Nadia Petrova
Initiated
2022-07-09
Description

Facility Change for Semaglutidex — minor update

Impacted Markets (4)
US — United StatesCN — ChinaSA — Saudi ArabiaBE — Belgium
Impacted Modules
5.3.53.2.P.3
Linked Variations (0)
Variation #TypeApplicationStatusSubmittedApproved